ADVFN ADVFN

Hot Features

Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Newron Pharmaceuticals Spa.

Newron Pharmaceuticals Spa. (NP5)

13.25
0.10
(0.76%)
終了 6月9日 5:00AM

Newron Pharmaceuticals Spa. (NP5) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
13.25
( 0.76% )
買値
13.20
売値
13.25
出来高
2,204
12.80 日の範囲 13.25
7.05 52 週間の範囲 34.15
時価総額
前日終値
13.15
始値
13.15
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
81,652 €
発行済株式数
20,014,585
配当利回り
PER
-19.92
1 株当たり利益 (EPS)
-0.66
歳入
19.13M
純利益
-13.24M

Newron Pharmaceuticals Spa. について

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European... Newron Pharmaceuticals S.p.A., a biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson’s in the European Union, the United Kingdom, the United States, Latin America, Switzerland, and Japan. The company’s lead compound includes Evenamide, an add-on therapy for the treatment of Schizophrenia and treatment-resistant schizophrenia, which is in Phase III clinical trial; and Ralfinamide for the treatment of rare neuropathic pain indication. It has a strategic partnership with Zambon and Meiji Seika Pharma Co., Ltd. for the commercialization of safinamide. Newron Pharmaceuticals S.p.A. was founded in 1999 and is headquartered in Bresso, Italy. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Bresso, Italy
設立
1999
Newron Pharmaceuticals Spa. is listed in the Healthcare sector of the Tradegate (DE) with ticker NP5. The last closing price for Newron Pharmaceuticals was 13.15 €. Over the last year, Newron Pharmaceuticals shares have traded in a share price range of 7.05 € to 34.15 €.

Newron Pharmaceuticals currently has 20,014,585 shares in issue. The market capitalisation of Newron Pharmaceuticals is 265.19 € million. Newron Pharmaceuticals has a price to earnings ratio (PE ratio) of -19.92.

NP5 最新ニュース

表示するニュースはありません。
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-2.2-14.239482200615.4515.4512.8895213.55596837DE
4-1.65-11.073825503414.916.7512.8523814.71606367DE
12-5.01-27.437020810518.261912.75532015.80418805DE
26-7.05-34.729064039420.334.1512.75701221.35649936DE
524.7555.88235294128.534.157.05606817.470006DE
1568.89203.8990825694.3634.154.2735310.86854761DE
26010.87456.7226890762.3834.151.1356449.66751037DE

NP5 - Frequently Asked Questions (FAQ)

What is the current Newron Pharmaceuticals Spa. share price?
The current share price of Newron Pharmaceuticals Spa. is 13.25 €
How many Newron Pharmaceuticals Spa. shares are in issue?
Newron Pharmaceuticals Spa. has 20,014,585 shares in issue
What is the market cap of Newron Pharmaceuticals Spa.?
The market capitalisation of Newron Pharmaceuticals Spa. is EUR 265.19M
What is the 1 year trading range for Newron Pharmaceuticals Spa. share price?
Newron Pharmaceuticals Spa. has traded in the range of 7.05 € to 34.15 € during the past year
What is the PE ratio of Newron Pharmaceuticals Spa.?
The price to earnings ratio of Newron Pharmaceuticals Spa. is -19.92
What is the cash to sales ratio of Newron Pharmaceuticals Spa.?
The cash to sales ratio of Newron Pharmaceuticals Spa. is 13.82
What is the registered address of Newron Pharmaceuticals Spa.?
The registered address for Newron Pharmaceuticals Spa. is Via Antonio Meucci 3, Bresso, Milan, 20091
What is the Newron Pharmaceuticals Spa. website address?
The website address for Newron Pharmaceuticals Spa. is www.newron.com
Which industry sector does Newron Pharmaceuticals Spa. operate in?
Newron Pharmaceuticals Spa. operates in the Biotechnology & Life Sciences sector

NP5 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock